Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial

Fig. 5

Adjusted mean change from baseline in a SGRQ and b CAT total scores (overall population, ITT). †p < 0.01; ‡p < 0.001. Data are adjusted mean and 95% CI. The N values are the number of patients included in the statistical model. SGRQ St George’s Respiratory Questionnaire, CAT COPD Assessment Test, ITT intention-to-treat, BDP beclometasone dipropionate, FF formoterol fumarate, G glycopyrronium, BUD budesonide, CI confidence interval

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us